|
A2033T SNP Allele by Ethnicity |
|||
| CROHN'S PATIENTS |
T Allele Absent |
T Allele Present |
Total |
|
|
|||
| Acadian |
10 (53%) |
9 (47%) |
19 |
| African-American |
17 (85%) |
3 (15%) |
20 |
| Caucasian |
44 (75%) |
15 (25%) |
59 |
| Hispanic |
2 (100%) |
0 (0%) |
2 |
| Jewish |
4 (80%) |
1 (20%) |
5 |
| Unknown |
4 (67%) |
2 (23%) |
6 |
| Total |
81 |
30 |
111 |
|
|
|||
| CONTROL PATIENTS |
T Allele Absent |
T Allele Present |
Total |
|
|
|||
| Acadian |
36 (84%) |
7 (16%) |
43 |
| African-American |
4 (57%) |
3 (43%) |
7 |
| Caucasian |
32 (91%) |
3 (9%) |
35 |
| Hispanic |
7 (87%) |
1 (13%) |
8 |
| Jewish |
3 (100%) |
0 (0%) |
3 |
| Unknown |
12 (100%) |
0 (0%) |
12 |
| Total |
94 |
14 |
108 |
Zapata-Velandia et al. Journal of Immune Based Therapies and Vaccines 2004 2:6 doi:10.1186/1476-8518-2-6 |
|||